Identifying Selection Criteria for Non-radical Hysterectomy in FIGO Stage IB Cervical Cancer

Overview

Journal J Obstet Gynaecol Res

Specialty Gynecology & Obstetrics

Date 2019 Jan 24

PMID 30672089

Citations 3

Authors

Takahiro Kasamatsu

Mitsuya Ishikawa

Naoya Murakami

Satoshi Okada

Shun-Ichi Ikeda

Tomoyasu Kato

Jun Itami

Affiliations

Soon will be listed here.

Abstract

Aim: This retrospective study sought to identify the selection criteria required for a non-radical hysterectomy with minimal parametrectomy in patients with International Federation of Gynecology and Obstetrics (FIGO) stage IB invasive cervical cancer.

Methods: Overall, 461 patients with FIGO stage IB cervical cancer who underwent a radical hysterectomy were reviewed clinicopathologically according to pathological tumor size (≤2 cm, >2 - ≤4 cm, and > 4 cm).

Results: The pathological parametrial involvement rate in the less than equal to 2 cm group (2%) was significantly lower than in greater than 2-less than equal to 4 cm (13%) or greater than 4 cm (29%) groups (both P < 0.001). The 5-year overall survival rate was significantly higher in the less than equal to 2 cm group (97%, 95% confidence interval [CI] 94-99%) compared with greater than 2-less than equal to 4 cm (90%, 95% CI 94-86%) and greater than 4 cm (70%, 95% CI 79-60%) groups (both P < 0.001). Cox model analysis identified tumor size to be an independent prognostic factor for survival (95% CI 1.33-5.78) and recurrence (95% CI 1.31-5.66) compared to other pathological factors. However, a significant difference between the three groups was not found in rates of Grade 3 or 4 adverse events following radical hysterectomy (P = 0.19).

Conclusions: Tumor size is an independent prognostic factor for survival in patients with FIGO stage IB invasive cervical cancer. This retrospective study suggests that FIGO stage IB patients with a less than equal to 2 cm tumor size are optimal candidates for non-radical hysterectomy with minimal parametrectomy, and without resulting bladder dysfunction.

Citing Articles

A Multicenter Study on the Relationship of Tumor Lesion Location with Bilateral Parametrial Involvement and Pelvic Lymph Node Metastasis in Cervical Squamous Cell Carcinoma.

Tang X, Yang B, Bian W, Li K, Pan S, Zhu W Ann Surg Oncol. 2025; .

PMID: 39863803 DOI: 10.1245/s10434-024-16802-8.

Reverse shock index multiplied by simplified motor score as a predictor of clinical outcomes for patients with COVID-19.

Wu M, Hou Y, Chung J, Yiang G BMC Emerg Med. 2024; 24(1):26.

PMID: 38355419 PMC: 10865660. DOI: 10.1186/s12873-024-00948-5.

Patient, disease, and survival outcomes for stage IB to stage IV cervical cancer-A population study.

Wang C, Lester B, Huang L, Sun S, Ko J Womens Health (Lond). 2023; 19:17455057231164551.

PMID: 37052298 PMC: 10102945. DOI: 10.1177/17455057231164551.

Effect of crisis intervention nursing on perioperative psychological state and self-efficacy of patients undergoing laparoscopic radical hysterectomy.

Li Y, Chen S, Xu M, Liu J Am J Transl Res. 2021; 13(11):12988-12995.

PMID: 34956515 PMC: 8661230.

References

Bergmark K, Avall-Lundqvist E, Dickman P, Henningsohn L, Steineck G . Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med. 1999; 340(18):1383-9. DOI: 10.1056/NEJM199905063401802. View

Benedet J, Bender H, Jones 3rd H, Ngan H, Pecorelli S . FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2000; 70(2):209-62. View

Landoni F, Maneo A, Cormio G, Perego P, Milani R, Caruso O . Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001; 80(1):3-12. DOI: 10.1006/gyno.2000.6010. View

Covens A, Rosen B, Murphy J, Laframboise S, Depetrillo A, Lickrish G . Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years. Gynecol Oncol. 2001; 81(2):133-7. DOI: 10.1006/gyno.2001.6158. View

Covens A, Rosen B, Murphy J, Laframboise S, Depetrillo A, Lickrish G . How important is removal of the parametrium at surgery for carcinoma of the cervix?. Gynecol Oncol. 2001; 84(1):145-9. DOI: 10.1006/gyno.2001.6493. View

Zullo M, Manci N, Angioli R, Muzii L, Benedetti Panici P . Vesical dysfunctions after radical hysterectomy for cervical cancer: a critical review. Crit Rev Oncol Hematol. 2003; 48(3):287-93. DOI: 10.1016/s1040-8428(03)00125-2. View

Bergmark K, Avall-Lundqvist E, Dickman P, Henningsohn L, Steineck G . Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls. Int J Gynecol Cancer. 2006; 16(3):1130-9. DOI: 10.1111/j.1525-1438.2006.00601.x. View

Stegeman M, Louwen M, Velden J, Ten Kate F, den Bakker M, Burger C . The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy. Gynecol Oncol. 2007; 105(2):475-80. DOI: 10.1016/j.ygyno.2007.01.016. View

Kasamatsu T, Onda T, Sawada M, Kato T, Ikeda S . Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation. Gynecol Oncol. 2009; 114(1):69-74. DOI: 10.1016/j.ygyno.2009.03.026. View

10.

Kasamatsu T, Onda T, Sawada M, Kato T, Ikeda S, Sasajima Y . Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix. Br J Cancer. 2009; 100(9):1400-5. PMC: 2694432. DOI: 10.1038/sj.bjc.6605048. View

11.

Frumovitz M, Sun C, Schmeler K, Deavers M, Dos Reis R, Levenback C . Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol. 2009; 114(1):93-99. DOI: 10.1097/AOG.0b013e3181ab474d. View

12.

Park J, Kim D, Kim J, Kim Y, Kim Y, Nam J . Outcomes after radical hysterectomy according to tumor size divided by 2-cm interval in patients with early cervical cancer. Ann Oncol. 2010; 22(1):59-67. DOI: 10.1093/annonc/mdq321. View

13.

Smith A, Frumovitz M, Schmeler K, Dos Reis R, Nick A, Coleman R . Conservative surgery in early-stage cervical cancer: what percentage of patients may be eligible for conization and lymphadenectomy?. Gynecol Oncol. 2010; 119(2):183-6. PMC: 4286388. DOI: 10.1016/j.ygyno.2010.07.015. View

14.

Reade C, Eiriksson L, Covens A . Surgery for early stage cervical cancer: how radical should it be?. Gynecol Oncol. 2013; 131(1):222-30. DOI: 10.1016/j.ygyno.2013.07.078. View

15.

Ramirez P, Pareja R, Rendon G, Millan C, Frumovitz M, Schmeler K . Management of low-risk early-stage cervical cancer: should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care?. Gynecol Oncol. 2013; 132(1):254-9. PMC: 4286394. DOI: 10.1016/j.ygyno.2013.09.004. View

16.

Horn L, Bilek K, Fischer U, Einenkel J, Hentschel B . A cut-off value of 2 cm in tumor size is of prognostic value in surgically treated FIGO stage IB cervical cancer. Gynecol Oncol. 2014; 134(1):42-6. DOI: 10.1016/j.ygyno.2014.04.011. View

17.

Kunieda F, Kasamatsu T, Arimoto T, Onda T, Toita T, Shibata T . Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101). Jpn J Clin Oncol. 2014; 45(1):123-6. DOI: 10.1093/jjco/hyu168. View

18.

Koh W, Greer B, Abu-Rustum N, Apte S, Campos S, Cho K . Cervical Cancer, Version 2.2015. J Natl Compr Canc Netw. 2015; 13(4):395-404. DOI: 10.6004/jnccn.2015.0055. View

19.

Arimoto T, Kawana K, Adachi K, Ikeda Y, Nagasaka K, Tsuruga T . Minimization of curative surgery for treatment of early cervical cancer: a review. Jpn J Clin Oncol. 2015; 45(7):611-6. DOI: 10.1093/jjco/hyv048. View

20.

Lennox G, Covens A . Management Of Early Stage Cervical Cancer: When Is Non-Randomized Data Good Enough?. Gynecol Oncol. 2017; 146(1):1-2. DOI: 10.1016/j.ygyno.2017.06.006. View